Specialty / Expertise

Breast Cancer

Research Interests

Current Research Projects

Research Staff

Training

Dr. Lu received her MD from Sun Yat-sen University of Medical Sciences, Guangzhou, PRC and her PhD from the University of Washington, Seattle, WA. She was a Post-Doctoral Fellow at the Fred Hutchinson Cancer Research Center, Seattle, WA.

Selected Publications:

Lu H, Goodell V, Disis ML. Targeting serum antibody for cancer diagnosis: a focus on colorectal cancer. Expert Opin Ther Targets 2007; 11: 235-44

Lu H, Knutson KL, Gad E, Disis ML. The tumor antigen repertoire identified in tumor bearing neu transgenic mice predicts human tumor antigens. Cancer Res 2006; 66: 9754-61

Knutson KL, Lu H, Stone B, Reiman JM, Behrens MD, Prosperi CM, Gad EA, Smorlesi A, Disis ML. Immunoediting of cancers may lead to epithelial to mesenchymal transition. J Immunol 2006;177:1526-33

Knutson KL, Dang Y, Lu H, Lukas J, Almand B, Gad E, Azeke E, Disis ML. IL-2 immunotoxin therapy modulates tumor-associated regulatory T cells and leads to lasting immune-mediated rejection of breast cancers in neu-transgenic mice. J Immunol 2006;177:84-91

Lu H, Zhao Z, Kalina T, Gillespy T, 3rd, Liggitt D, Andrews RG, Maloney DG, Kiem HP, Storek J. Interleukin-7 improves reconstitution of antiviral CD4 T cells. Clin Immunol 2005;114:30-41